…
Rest EZ, Inc. produces and distributes sleeping aid soft gel capsules in the United States. The company offers Rest EZ, a sleep aid supplement soft gel capsule. It sells its products through wholesalers and retailers, as well as online through www.RestEz.net. The company was formerly known as Amazing Ventures, Inc. and changed its name to Rest EZ, Inc. in February 2018. Rest EZ, Inc. was incorporated in 2016 and is based in West Jordan, Utah.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Income before tax | -0.01M | -0.02M | -0.02M | -0.43M | 0.21M |
| Net income | -0.01M | -0.02M | -0.02M | -0.43M | 0.17M |
| Selling general administrative | 0.01M | 0.02M | 0.02M | 0.01M | 0.03M |
| Gross profit | 0.00M | 0.00M | 0.00M | 0.00M | 0.25M |
| Ebitda | -0.01M | -0.02M | - | -0.42M | 0.22M |
| Operating income | -0.01M | -0.02M | -0.02M | -0.42M | 0.22M |
| Other operating expenses | - | 0.02M | - | 0.42M | 0.30M |
| Interest expense | - | - | 0.00M | 0.01M | 0.01M |
| Tax provision | 0.00M | 0.00M | 0.00M | 0.00M | 0.04M |
| Net interest income | - | - | 0.00M | -0.01M | -0.01M |
| Income tax expense | - | - | - | - | 0.04M |
| Total revenue | 0.00M | 0.01M | 0.01M | 0.00M | 0.52M |
| Total operating expenses | 0.01M | 0.02M | 0.02M | 0.42M | 0.03M |
| Cost of revenue | 0.00M | 0.00M | 0.00M | 0.00M | 0.27M |
| Total other income expense net | - | - | - | -0.01M | -0.01M |
| Net income from continuing ops | -0.01M | -0.01M | -0.02M | -0.43M | 0.17M |
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Total assets | 0.00M | 0.01M | 0.01M | 0.00M | 0.41M |
| Other current assets | - | - | - | - | 0.41M |
| Total liab | 0.02M | 0.05M | 0.05M | 0.17M | 0.16M |
| Total stockholder equity | -0.01M | -0.04M | -0.04M | -0.17M | 0.25M |
| Other current liab | 0.02M | - | - | - | - |
| Common stock | 0.06M | 0.03M | - | 0.02M | 0.02M |
| Capital stock | 0.06M | 0.03M | 0.03M | 0.02M | 0.02M |
| Retained earnings | -0.33M | -0.32M | -0.32M | -0.31M | 0.12M |
| Cash | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total current liabilities | 0.02M | 0.05M | 0.05M | 0.17M | 0.16M |
| Net debt | -0.00M | 0.01M | 0.01M | 0.13M | 0.12M |
| Short term debt | - | 0.01M | - | 0.13M | 0.12M |
| Short long term debt | 0.02M | - | 0.01M | 0.13M | 0.12M |
| Short long term debt total | - | 0.01M | - | 0.13M | 0.12M |
| Other stockholder equity | 0.26M | 0.26M | - | 0.12M | 0.11M |
| Total current assets | 0.00M | 0.01M | 0.01M | 0.00M | 0.41M |
| Net receivables | 0.00M | 0.01M | 0.01M | 0.00M | - |
| Inventory | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Accounts payable | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Non current assets total | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Breakdown | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
| Net borrowings | - | - | 0.00M | 0.01M | 0.01M |
| Total cash from financing activities | 0.05M | 0.10M | 0.10M | 0.01M | 0.07M |
| Net income | -0.01M | -0.02M | -0.02M | -0.43M | 0.17M |
| Change in cash | 0.00M | -0.00M | -0.00M | -0.00M | -0.01M |
| Begin period cash flow | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M |
| End period cash flow | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Total cash from operating activities | 0.00M | -0.10M | -0.10M | -0.01M | -0.08M |
| Issuance of capital stock | 0.03M | 0.00M | 0.15M | 0.00M | 0.08M |
| Change to inventory | 0.00M | 0.00M | 0.00M | 0.00M | 0.02M |
| Change to account receivables | 0.01M | -0.01M | -0.01M | - | - |
| Other cashflows from financing activities | 0.05M | -0.05M | - | - | -0.02M |
| Capital expenditures | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Change in working capital | 0.02M | -0.08M | -0.08M | 0.00M | -0.26M |
| Other non cash items | 0.02M | - | - | 0.42M | 0.01M |
| Free cash flow | 0.00M | -0.10M | -0.10M | -0.01M | -0.08M |
Sector: Healthcare Industry: Pharmaceutical Retailers
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| RTEZ Rest EZ Inc. |
- -% |
70.00 | - | - | 385518.44 | 5.92 |
| JDHIF JD Health International Inc |
- -% |
4.79 | 15.09 | 15.11 | 0.18 | 1.52 |
| ALBBY Alibaba Health Information Technology Limited |
- -% |
7.65 | 34.43 | 19.84 | 0.29 | 3.79 |
| RADLY Raia Drogasil SA ADR |
0.09 3.35% |
2.78 | 22.35 | 24.69 | 0.14 | 4.59 |
| ALBHF Alibaba Health Information Technology Limited |
- -% |
0.33 | 17.35 | 16.69 | 0.16 | 2.11 |
Rest EZ, Inc. produces and distributes sleeping aid soft gel capsules in the United States. The company offers Rest EZ, a sleep aid supplement soft gel capsule. It sells its products through wholesalers and retailers, as well as online through www.RestEz.net. The company was formerly known as Amazing Ventures, Inc. and changed its name to Rest EZ, Inc. in February 2018. Rest EZ, Inc. was incorporated in 2016 and is based in West Jordan, Utah.
| Name | Title | Year Born |
|---|---|---|
| Mr. Dylan Carson | Chairman, President, CEO & CFO | 1992 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.